Literature DB >> 17337467

Detection of HP10 antigen in serum for diagnosis and follow-up of subarachnoidal and intraventricular human neurocysticercosis.

A Fleury1, M Hernández, M Avila, G Cárdenas, R J Bobes, M Huerta, G Fragoso, L Uribe-Campero, L J S Harrison, R M E Parkhouse, E Sciutto.   

Abstract

INTRODUCTION: Neurocysticercosis (NC), a parasitic disease caused by Taenia solium, may be either asymptomatic or show a mild to severe clinical picture with intracranial hypertension. The most severe form of the disease is caused when viable cysticerci are localised in the ventricles or in subarachnoidal cisterns at the base of the skull. Detection of the secreted metacestode antigen HP10 in cerebrospinal fluid is a sensitive and specific method for the diagnosis of these severe NC cases. OBJECTIVE AND METHODS: To evaluate the validity of HP10 antigen detection ELISA when applied to serum, using paired serum and cerebrospinal fluid samples from 116 radiologically and clinically characterised NC patients.
RESULTS: The HP10 antigen assay exhibited a similarly high sensitivity in identifying severe NC cases from sera (84.8%) and CSF (91.3%). In contrast, HP10 antigen was rarely detected in asymptomatic or mild NC cases (3 of 57). Importantly, the HP10 antigen assay applied to serum showed high specificity (94%) when used in 126 serum samples of non-NC subjects from an endemic community with a confirmed coproparasitological diagnosis of intestinal parasitic infections. Finally, the HP10 assay also proved to be of value in the follow-up of treated patients.
CONCLUSION: This study confirms that detection of the metacestode HP10 antigen in serum is a useful tool for diagnosis and follow-up of patients with severe forms of NC treated with cysticidal drugs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17337467      PMCID: PMC2117888          DOI: 10.1136/jnnp.2006.107243

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

1.  High prevalence of calcified silent neurocysticercosis in a rural village of Mexico.

Authors:  A Fleury; T Gomez; I Alvarez; D Meza; M Huerta; A Chavarria; R A Carrillo Mezo; C Lloyd; A Dessein; P M Preux; M Dumas; C Larralde; E Sciutto; G Fragoso
Journal:  Neuroepidemiology       Date:  2003 Mar-Apr       Impact factor: 3.282

2.  An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium).

Authors:  V C Tsang; J A Brand; A E Boyer
Journal:  J Infect Dis       Date:  1989-01       Impact factor: 5.226

3.  Immunodiagnosis of human cysticercosis in cerebrospinal fluid. Antigens from murine Taenia crassiceps cysticerci effectively substitute those from porcine Taenia solium.

Authors:  C Larralde; J Sotelo; R M Montoya; G Palencia; A Padilla; T Govezensky; M L Diaz; E Sciutto
Journal:  Arch Pathol Lab Med       Date:  1990-09       Impact factor: 5.534

4.  Specific detection of circulating surface/secreted glycoproteins of viable cysticerci in Taenia saginata cysticercosis.

Authors:  L J Harrison; G W Joshua; S H Wright; R M Parkhouse
Journal:  Parasite Immunol       Date:  1989-07       Impact factor: 2.280

5.  Serum antigen detection in the diagnosis, treatment, and follow-up of neurocysticercosis patients.

Authors:  H H Garcia; R M Parkhouse; R H Gilman; T Montenegro; T Bernal; S M Martinez; A E Gonzalez; V C Tsang; L J Harrison
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 Nov-Dec       Impact factor: 2.184

6.  Diagnosis of human neurocysticerocosis in endemic countries: a clinical study in Honduras.

Authors:  A L Sanchez; I Ljungström; M T Medina
Journal:  Parasitol Int       Date:  1999-03       Impact factor: 2.230

7.  Circulating parasite antigen in patients with hydrocephalus secondary to neurocysticercosis.

Authors:  H H Garcia; A E Gonzalez; R H Gilman; T Bernal; S Rodriguez; E J Pretell; O Azcurra; R M E Parkhouse; V C W Tsang; L J S Harrison
Journal:  Am J Trop Med Hyg       Date:  2002-04       Impact factor: 2.345

8.  Symptomatic human neurocysticercosis--age, sex and exposure factors relating with disease heterogeneity.

Authors:  Agnès Fleury; Alain Dessein; Pierre Marie Preux; Michel Dumas; Graciela Tapia; Carlos Larralde; Edda Sciutto
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

9.  Human neurocysticercosis: comparison of enzyme immunoassay capture techniques based on monoclonal and polyclonal antibodies for the detection of parasite products in cerebrospinal fluid.

Authors:  D Correa; M A Sandoval; L J Harrison; R M Parkhouse; A Plancarte; A Meza-Lucas; A Flisser
Journal:  Trans R Soc Trop Med Hyg       Date:  1989 Nov-Dec       Impact factor: 2.184

10.  Detection of secreted cysticercal antigen: a useful tool in the diagnosis of inflammatory neurocysticercosis.

Authors:  A Fleury; M Hernández; G Fragoso; R M E Parkhouse; L J S Harrison; E Sciutto
Journal:  Trans R Soc Trop Med Hyg       Date:  2003 Sep-Oct       Impact factor: 2.184

View more
  28 in total

1.  The HP10 Taenia monoclonal antibody-based ELISA detects a similar protein in the vesicular fluid of Taenia hydatigena.

Authors:  Maria M Cortez; Glenda C Rojas; R Michael E Parkhouse
Journal:  Trop Anim Health Prod       Date:  2017-11-16       Impact factor: 1.559

2.  Anti-Taenia solium monoclonal antibodies for the detection of parasite antigens in body fluids from patients with neurocysticercosis.

Authors:  Adriana Paredes; Patricia Sáenz; Miguel W Marzal; Miguel A Orrego; Yesenia Castillo; Andrea Rivera; Siddhartha Mahanty; Cristina Guerra-Giraldez; Hector H García; Theodore E Nash
Journal:  Exp Parasitol       Date:  2016-03-23       Impact factor: 2.011

3.  Neurocysticercosis: an update.

Authors:  Christina M Coyle
Journal:  Curr Infect Dis Rep       Date:  2014-11       Impact factor: 3.725

4.  Immunodiagnosis of human neurocysticercosis: comparative performance of serum diagnostic tests in Mexico.

Authors:  Marisela Hernández; Osvaldo-Germán Astudillo; Gustavo Diego; Jorge-Luis de-la-Rosa-Arana; Antonio Meza-Lucas; Ricardo García-Rodea; Matthew-L Romo; Andrea Toledo; R-Michael-E Parkhouse; Teresa Garate; Edda Sciutto; Agnès Fleury
Journal:  Parasitol Res       Date:  2019-08-15       Impact factor: 2.289

Review 5.  Extraparenchymal (Racemose) Neurocysticercosis and Its Multitude Manifestations: A Comprehensive Review.

Authors:  Rohan R Mahale; Anish Mehta; Srinivasa Rangasetty
Journal:  J Clin Neurol       Date:  2015-05-28       Impact factor: 3.077

6.  Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis.

Authors:  Silvia Rodriguez; Pierre Dorny; Victor C W Tsang; E Javier Pretell; Jef Brandt; Andres G Lescano; Armando E Gonzalez; Robert H Gilman; Hector H Garcia
Journal:  J Infect Dis       Date:  2009-05-01       Impact factor: 5.226

Review 7.  Immunological and molecular diagnosis of cysticercosis.

Authors:  Silvia Rodriguez; Patricia Wilkins; Pierre Dorny
Journal:  Pathog Glob Health       Date:  2012-09       Impact factor: 2.894

Review 8.  Diagnostic criteria for neurocysticercosis, revisited.

Authors:  Oscar H Del Brutto
Journal:  Pathog Glob Health       Date:  2012-09       Impact factor: 2.894

Review 9.  Epilepsy and neurocysticercosis in sub-Saharan Africa.

Authors:  Andrea Sylvia Winkler; Arve Lee Willingham; Chummy Sikalizyo Sikasunge; Erich Schmutzhard
Journal:  Wien Klin Wochenschr       Date:  2009-10       Impact factor: 1.704

10.  Diagnosis and treatment of neurocysticercosis.

Authors:  Christina M Coyle; Herbert B Tanowitz
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.